How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

Appraisals often bring a mix of excitement and nerves, but for one Bengaluru startup employee, the latest review brought joy not just to him, but to his entire family. Raj Vikramaditya, founder of ...

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That’s, it’s a ...

Hiring in the age of artificial intelligence is becoming increasingly difficult, with one Bengaluru founder saying a flood of low-effort, AI-generated applications is making it harder to spot genuine ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Team India players, KL Rahul and Sanju Samson, shared a heartwarming moment at the BCCI Naman Awards in New Delhi on Sunday, March 15. The Board of Control for Cricket in India (BCCI) hosted the Naman ...

Gain the skills, dexterity and confidence to propel your career into senior management. Whether the goal is to create a standalone solution or fashion part of a complex talent development initiative, ...

In 1963, Pete Dye and his wife, Alice, toured the British Isles and studied the architecture of the region's great courses. The trip would have a profound influence on their philosophies around golf ...

That post quickly picked up traction, with many opining about the usage of AI in resumes and job interviews.